{
  "url": "https://finance.yahoo.com/news/tactile-systems-technology-second-quarter-124533459.html",
  "authorsByline": "Simply Wall St",
  "articleId": "85fa9d48744d4793bbb56f3eba14f1f4",
  "source": {
    "domain": "finance.yahoo.com",
    "location": {
      "country": "us",
      "state": "CA",
      "county": "Santa Clara County",
      "city": "Sunnyvale",
      "coordinates": {
        "lat": 37.3688301,
        "lon": -122.036349
      }
    }
  },
  "imageUrl": "https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c",
  "country": "us",
  "language": "en",
  "pubDate": "2025-08-07T12:45:33+00:00",
  "addDate": "2025-08-07T12:57:34.025308+00:00",
  "refreshDate": "2025-08-07T12:57:34.025311+00:00",
  "score": 1.0,
  "title": "Tactile Systems Technology Second Quarter 2025 Earnings: Beats Expectations",
  "description": "NasdaqGM:TCMD 1 Year Share Price vs Fair Value Explore Tactile Systems Technology's Fair Values from the Community and...",
  "content": "Explore Tactile Systems Technology's Fair Values from the Community and select yours\n\u2022 Profit margin: 4.1% (down from 5.9% in 2Q 2024). The decrease in margin was driven by higher expenses.\n\u2022 EPS: US$0.14 (down from US$0.18 in 2Q 2024).\n\nThis technology could replace computers: discover the 20 stocks are working to make quantum computing a reality.\n\nAll figures shown in the chart above are for the trailing 12 month (TTM) period\n\nRevenue exceeded analyst estimates by 6.7%. Earnings per share (EPS) also surpassed analyst estimates by 30%.\n\nLooking ahead, revenue is forecast to grow 8.6% p.a. on average during the next 3 years, compared to a 8.2% growth forecast for the Medical Equipment industry in the US.\n\nThe company's shares are up 22% from a week ago.\n\nBefore you take the next step you should know about the 2 warning signs for Tactile Systems Technology that we have uncovered.\n\nHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.\n\n\n\nThis article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.",
  "medium": "Article",
  "links": [
    "https://simplywall.st/discover/investing-ideas/282/quantum-computing-stocks/global?blueprint=3969492&utm_medium=finance_user&utm_campaign=investing-ideas&utm_source=yahoo&utm_content=quantum-computing",
    "https://simplywall.st/company/id/B8520121-8444-4CBC-8177-2E715274AC69?blueprint=3969492&utm_medium=finance_user&utm_campaign=conclusion&utm_source=yahoo",
    "https://simplywall.st/markets/us/healthcare/medical-equipment?blueprint=3969492&utm_medium=finance_user&utm_campaign=industry&utm_source=yahoo",
    "https://au.finance.yahoo.com/quote/TCMD",
    "https://simplywall.st/company/id/B8520121-8444-4CBC-8177-2E715274AC69/future?blueprint=3969492&amp;utm_medium=finance_user&amp;utm_campaign=infographic&amp;utm_source=yahoo",
    "https://simplywall.st/company/id/B8520121-8444-4CBC-8177-2E715274AC69?blueprint=3969492&utm_medium=finance_user&utm_campaign=narratives-news-header&utm_source=yahoo&utm_content=narrative-header-company-report"
  ],
  "labels": [
    {
      "name": "Roundup"
    }
  ],
  "claim": "",
  "verdict": "",
  "keywords": [
    {
      "name": "Tactile Systems Technology",
      "weight": 0.09383775
    },
    {
      "name": "analyst forecasts",
      "weight": 0.0861092
    },
    {
      "name": "Simply Wall St",
      "weight": 0.0798049
    },
    {
      "name": "analyst estimates",
      "weight": 0.078957446
    },
    {
      "name": "Profit margin",
      "weight": 0.067804575
    },
    {
      "name": "historical data",
      "weight": 0.06704994
    },
    {
      "name": "Tactile Systems Technology Second Quarter 2025 Earnings",
      "weight": 0.066714935
    },
    {
      "name": "fundamental data",
      "weight": 0.063048564
    },
    {
      "name": "Tactile Systems Technologys Fair Values",
      "weight": 0.062571496
    },
    {
      "name": "financial advice",
      "weight": 0.059179112
    }
  ],
  "topics": [
    {
      "name": "Markets"
    }
  ],
  "categories": [
    {
      "name": "Finance"
    }
  ],
  "taxonomies": [
    {
      "name": "/News/Business News/Financial Markets News",
      "score": 0.9716796875
    },
    {
      "name": "/Finance/Investing/Stocks & Bonds",
      "score": 0.94384765625
    },
    {
      "name": "/News/Business News/Company News",
      "score": 0.9326171875
    }
  ],
  "sentiment": {
    "positive": 0.24914551,
    "negative": 0.33740234,
    "neutral": 0.4128418
  },
  "summary": "Tactile Systems Technology's Q2 2025 earnings exceeded analyst estimates by 6.7% and its earnings per share (EPS) surpassed analyst forecasts by 30%. The company's profit margin was reduced to 4.1%, driven by higher expenses, and its EPS was also reduced to US$0.14 (down from 2Q 2024). Looking ahead, revenue is expected to grow 8.6% p.a. on average over the next three years, compared to a 8.2% growth forecast for the Medical Equipment industry in the US. The company\u2019s shares are up 22% from a week ago.",
  "shortSummary": "Tactile Systems Technology's Q2 earnings beat expectations, despite a 4.1% profit margin drop, with forecasted growth of 8.6% per year.",
  "translation": "",
  "translatedTitle": "",
  "translatedDescription": "",
  "translatedSummary": "",
  "reprint": false,
  "reprintGroupId": "434d199f1ccd4c57a514fb73a7f8318d",
  "places": [],
  "scraped_sources": [
    {
      "url": "https://simplywall.st/company/id/B8520121-8444-4CBC-8177-2E715274AC69?blueprint=3969492&utm_medium=finance_user&utm_campaign=conclusion&utm_source=yahoo",
      "text": "Tactile Systems Technology (TCMD) Stock Overview\nA medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. More details\n| Snowflake Score | |\n|---|---|\n| Valuation | 5/6 |\n| Future Growth | 3/6 |\n| Past Performance | 2/6 |\n| Financial Health | 5/6 |\n| Dividends | 0/6 |\nTCMD Community Fair Values\nSee what 16 others think this stock is worth. Follow their fair value or set your own to get alerts.\nTactile Systems Technology, Inc. Competitors\nPrice History & Performance\n| Historical stock prices | |\n|---|---|\n| Current Share Price | US$12.54 |\n| 52 Week High | US$21.10 |\n| 52 Week Low | US$8.61 |\n| Beta | 0.96 |\n| 1 Month Change | 23.79% |\n| 3 Month Change | 30.08% |\n| 1 Year Change | -4.57% |\n| 3 Year Change | 33.40% |\n| 5 Year Change | -67.09% |\n| Change since IPO | 13.18% |\nRecent News & Updates\nTactile Systems Technology's (NASDAQ:TCMD) Soft Earnings Don't Show The Whole Picture\nMay 12Slammed 28% Tactile Systems Technology, Inc. (NASDAQ:TCMD) Screens Well Here But There Might Be A Catch\nMay 08Why Tactile Systems Technology, Inc. (NASDAQ:TCMD) Could Be Worth Watching\nMay 07Recent updates\nTactile Systems Technology's (NASDAQ:TCMD) Soft Earnings Don't Show The Whole Picture\nMay 12Slammed 28% Tactile Systems Technology, Inc. (NASDAQ:TCMD) Screens Well Here But There Might Be A Catch\nMay 08Why Tactile Systems Technology, Inc. (NASDAQ:TCMD) Could Be Worth Watching\nMay 07Tactile Systems Technology: Interesting Devices Company, Need More Clarity\nApr 07Tactile Systems Technology (NASDAQ:TCMD) Has A Rock Solid Balance Sheet\nFeb 23Investors Appear Satisfied With Tactile Systems Technology, Inc.'s (NASDAQ:TCMD) Prospects As Shares Rocket 26%\nNov 25Tactile Systems Technology, Inc. Just Recorded A 18% EPS Beat: Here's What Analysts Are Forecasting Next\nNov 07Nimbl Approval And Tech Investments Propel Growth Amid Shrinking Margins And Operational Risks\nInvestments in technology and workflow improvements, alongside FDA approval for Nimbl, indicate a strong focus on innovation and market expansion.Investors Holding Back On Tactile Systems Technology, Inc. (NASDAQ:TCMD)\nJul 17US$20.67: That's What Analysts Think Tactile Systems Technology, Inc. (NASDAQ:TCMD) Is Worth After Its Latest Results\nMay 09Tactile Systems Technology, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next\nFeb 23Does Tactile Systems Technology (NASDAQ:TCMD) Have A Healthy Balance Sheet?\nOct 10Capital Allocation Trends At Tactile Systems Technology (NASDAQ:TCMD) Aren't Ideal\nSep 16Is It Time To Consider Buying Tactile Systems Technology, Inc. (NASDAQ:TCMD)?\nJul 13Are Investors Undervaluing Tactile Systems Technology, Inc. (NASDAQ:TCMD) By 26%?\nMay 10Is Tactile Systems Technology (NASDAQ:TCMD) Using Too Much Debt?\nFeb 16Is Tactile Systems Technology (NASDAQ:TCMD) A Risky Investment?\nOct 12Tactile Systems Technology GAAP EPS of -$0.23 misses by $0.09, revenue of $59.6M beats by $2.72M\nAug 01Is Tactile Systems Technology (NASDAQ:TCMD) A Risky Investment?\nJun 14Investors Could Be Concerned With Tactile Systems Technology's (NASDAQ:TCMD) Returns On Capital\nJan 20Shareholder Returns\n| TCMD | US Medical Equipment | US Market | |\n|---|---|---|---|\n| 7D | 21.6% | -2.7% | -0.2% |\n| 1Y | -4.6% | 7.7% | 22.4% |\nReturn vs Industry: TCMD underperformed the US Medical Equipment industry which returned 10.6% over the past year.\nReturn vs Market: TCMD underperformed the US Market which returned 22.8% over the past year.\nPrice Volatility\n| TCMD volatility | |\n|---|---|\n| TCMD Average Weekly Movement | 12.4% |\n| Medical Equipment Industry Average Movement | 8.4% |\n| Market Average Movement | 6.5% |\n| 10% most volatile stocks in US Market | 17.6% |\n| 10% least volatile stocks in US Market | 3.1% |\nStable Share Price: TCMD's share price has been volatile over the past 3 months compared to the US market.\nVolatility Over Time: TCMD's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of US stocks.\nAbout the Company\n| Founded | Employees | CEO | Website |\n|---|---|---|---|\n| 1995 | 1,037 | Sheri Dodd | tactilemedical.com |\nTactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers. The company also provides Nimbl, a pneumatic compression platform for the treatment of upper extremity lymphedema; Kylee, a mobile application to help patients learn about lymphedema, track their symptoms, and treatment, as well as to share their progress with their doctor; and AffloVest, a portable high frequency chest wall oscillation vest to treat patients with retained pulmonary secretions resulting from bronchiectasis, cystic fibrosis, and various neuromuscular disorders.\nTactile Systems Technology, Inc. Fundamentals Summary\n| TCMD fundamental statistics | |\n|---|---|\n| Market cap | US$220.47m |\n| Earnings (TTM) | US$15.11m |\n| Revenue (TTM) | US$298.85m |\nIs TCMD overvalued?\nSee Fair Value and valuation analysisEarnings & Revenue\n| TCMD income statement (TTM) | |\n|---|---|\n| Revenue | US$298.85m |\n| Cost of Revenue | US$75.56m |\n| Gross Profit | US$223.30m |\n| Other Expenses | US$208.18m |\n| Earnings | US$15.11m |\nLast Reported Earnings\nJun 30, 2025\nNext Earnings Date\nn/a\n| Earnings per share (EPS) | 0.68 |\n| Gross Margin | 74.72% |\n| Net Profit Margin | 5.06% |\n| Debt/Equity Ratio | 12.7% |\nHow did TCMD perform over the long term?\nSee historical performance and comparisonCompany Analysis and Financial Data Status\n| Data | Last Updated (UTC time) |\n|---|---|\n| Company Analysis | 2025/08/05 06:44 |\n| End of Day Share Price | 2025/08/05 00:00 |\n| Earnings | 2025/06/30 |\n| Annual Earnings | 2024/12/31 |\nData Sources\nThe data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.\n| Package | Data | Timeframe | Example US Source * |\n|---|---|---|---|\n| Company Financials | 10 years |\n| |\n| Analyst Consensus Estimates | +3 years |\n|\n|\n| Market Prices | 30 years |\n| |\n| Ownership | 10 years |\n| |\n| Management | 10 years |\n| |\n| Key Developments | 10 years |\n|\n* Example for US securities, for non-US equivalent regulatory forms and sources are used.\nUnless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.\nAnalysis Model and Snowflake\nDetails of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.\nLearn about the world class team who designed and built the Simply Wall St analysis model.\nIndustry and Sector Metrics\nOur industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.\nAnalyst Sources\nTactile Systems Technology, Inc. is covered by 13 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.\n| Analyst | Institution |\n|---|---|\n| null null | Argus Research Company |\n| Anderson Schock | B. Riley Securities, Inc. |\n| Kyle Bauser | B. Riley Securities, Inc. |"
    },
    {
      "url": "https://simplywall.st/company/id/B8520121-8444-4CBC-8177-2E715274AC69/future?blueprint=3969492&amp;utm_medium=finance_user&amp;utm_campaign=infographic&amp;utm_source=yahoo",
      "text": "Tactile Systems Technology Future Growth\nFuture criteria checks 3/6\nTactile Systems Technology is forecast to grow earnings and revenue by 29.1% and 8.6% per annum respectively while EPS is expected to grow by 29.5% per annum.\nKey information\n29.1%\nEarnings growth rate\n29.51%\nEPS growth rate\n| Medical Equipment earnings growth | 12.3% |\n| Revenue growth rate | 8.6% |\n| Future return on equity | n/a |\n| Analyst coverage | Low |\n| Last updated | 05 Aug 2025 |\nRecent future growth updates\nRecent updates\nTactile Systems Technology's (NASDAQ:TCMD) Soft Earnings Don't Show The Whole Picture\nMay 12Slammed 28% Tactile Systems Technology, Inc. (NASDAQ:TCMD) Screens Well Here But There Might Be A Catch\nMay 08Why Tactile Systems Technology, Inc. (NASDAQ:TCMD) Could Be Worth Watching\nMay 07Tactile Systems Technology: Interesting Devices Company, Need More Clarity\nApr 07Tactile Systems Technology (NASDAQ:TCMD) Has A Rock Solid Balance Sheet\nFeb 23Investors Appear Satisfied With Tactile Systems Technology, Inc.'s (NASDAQ:TCMD) Prospects As Shares Rocket 26%\nNov 25Tactile Systems Technology, Inc. Just Recorded A 18% EPS Beat: Here's What Analysts Are Forecasting Next\nNov 07Nimbl Approval And Tech Investments Propel Growth Amid Shrinking Margins And Operational Risks\nInvestments in technology and workflow improvements, alongside FDA approval for Nimbl, indicate a strong focus on innovation and market expansion.Investors Holding Back On Tactile Systems Technology, Inc. (NASDAQ:TCMD)\nJul 17US$20.67: That's What Analysts Think Tactile Systems Technology, Inc. (NASDAQ:TCMD) Is Worth After Its Latest Results\nMay 09Tactile Systems Technology, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next\nFeb 23Does Tactile Systems Technology (NASDAQ:TCMD) Have A Healthy Balance Sheet?\nOct 10Capital Allocation Trends At Tactile Systems Technology (NASDAQ:TCMD) Aren't Ideal\nSep 16Is It Time To Consider Buying Tactile Systems Technology, Inc. (NASDAQ:TCMD)?\nJul 13Are Investors Undervaluing Tactile Systems Technology, Inc. (NASDAQ:TCMD) By 26%?\nMay 10Is Tactile Systems Technology (NASDAQ:TCMD) Using Too Much Debt?\nFeb 16Is Tactile Systems Technology (NASDAQ:TCMD) A Risky Investment?\nOct 12Tactile Systems Technology GAAP EPS of -$0.23 misses by $0.09, revenue of $59.6M beats by $2.72M\nAug 01Is Tactile Systems Technology (NASDAQ:TCMD) A Risky Investment?\nJun 14Investors Could Be Concerned With Tactile Systems Technology's (NASDAQ:TCMD) Returns On Capital\nJan 20Earnings and Revenue Growth Forecasts\n| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |\n|---|---|---|---|---|---|\n| 12/31/2027 | 377 | 37 | N/A | N/A | 1 |\n| 12/31/2026 | 338 | 21 | 50 | 52 | 5 |\n| 12/31/2025 | 313 | 15 | 43 | 44 | 5 |\n| 6/30/2025 | 299 | 15 | 39 | 42 | N/A |\n| 3/31/2025 | 293 | 16 | 38 | 40 | N/A |\n| 12/31/2024 | 293 | 17 | 38 | 41 | N/A |\n| 9/30/2024 | 285 | 15 | 40 | 43 | N/A |\n| 6/30/2024 | 282 | 33 | 34 | 37 | N/A |\n| 3/31/2024 | 277 | 28 | 35 | 37 | N/A |\n| 12/31/2023 | 274 | 29 | 33 | 36 | N/A |\n| 9/30/2023 | 271 | 25 | 20 | 21 | N/A |\n| 6/30/2023 | 266 | 0 | 17 | 20 | N/A |\n| 3/31/2023 | 258 | -4 | 6 | 8 | N/A |\n| 12/31/2022 | 247 | -18 | 3 | 5 | N/A |\n| 9/30/2022 | 235 | -30 | 4 | 7 | N/A |\n| 6/30/2022 | 222 | -31 | 2 | 4 | N/A |\n| 3/31/2022 | 213 | -25 | -2 | 0 | N/A |\n| 12/31/2021 | 208 | -12 | 0 | 3 | N/A |\n| 9/30/2021 | 206 | 8 | 0 | 2 | N/A |\n| 6/30/2021 | 202 | 14 | 7 | 9 | N/A |\n| 3/31/2021 | 186 | -2 | -1 | 1 | N/A |\n| 12/31/2020 | 187 | -1 | 1 | 3 | N/A |\n| 9/30/2020 | 185 | -8 | -5 | -2 | N/A |\n| 6/30/2020 | 185 | -8 | -11 | -6 | N/A |\n| 3/31/2020 | 196 | 8 | -3 | 2 | N/A |\n| 12/31/2019 | 189 | 11 | -3 | 3 | N/A |\n| 9/30/2019 | 179 | 9 | -3 | 8 | N/A |\n| 6/30/2019 | 166 | 8 | 2 | 11 | N/A |\n| 3/31/2019 | 155 | 8 | N/A | 12 | N/A |\n| 12/31/2018 | 144 | 7 | N/A | 9 | N/A |\n| 9/30/2018 | 132 | 6 | N/A | 8 | N/A |\n| 6/30/2018 | 124 | 6 | N/A | 6 | N/A |\n| 3/31/2018 | 116 | 7 | N/A | 2 | N/A |\n| 12/31/2017 | 109 | 6 | N/A | 4 | N/A |\n| 9/30/2017 | 103 | 6 | N/A | 3 | N/A |\n| 6/30/2017 | 97 | 5 | N/A | 3 | N/A |\n| 3/31/2017 | 91 | 2 | N/A | 8 | N/A |\n| 12/31/2016 | 85 | 2 | N/A | 7 | N/A |\n| 9/30/2016 | 77 | 0 | N/A | 7 | N/A |\n| 6/30/2016 | 71 | 0 | N/A | 4 | N/A |\n| 3/31/2016 | 66 | -1 | N/A | 2 | N/A |\n| 12/31/2015 | 63 | 0 | N/A | 2 | N/A |\n| 9/30/2015 | 60 | 0 | N/A | 1 | N/A |\n| 6/30/2015 | 55 | 0 | N/A | 1 | N/A |\n| 3/31/2015 | 49 | 0 | N/A | 0 | N/A |\n| 12/31/2014 | 48 | 0 | N/A | -1 | N/A |\nAnalyst Future Growth Forecasts\nEarnings vs Savings Rate: TCMD's forecast earnings growth (29.1% per year) is above the savings rate (3.1%).\nEarnings vs Market: TCMD's earnings (29.1% per year) are forecast to grow faster than the US market (14.7% per year).\nHigh Growth Earnings: TCMD's earnings are expected to grow significantly over the next 3 years.\nRevenue vs Market: TCMD's revenue (8.6% per year) is forecast to grow slower than the US market (9.2% per year).\nHigh Growth Revenue: TCMD's revenue (8.6% per year) is forecast to grow slower than 20% per year.\nEarnings per Share Growth Forecasts\nFuture Return on Equity\nFuture ROE: Insufficient data to determine if TCMD's Return on Equity is forecast to be high in 3 years time\nDiscover growth companies\nCompany Analysis and Financial Data Status\n| Data | Last Updated (UTC time) |\n|---|---|\n| Company Analysis | 2025/08/05 12:51 |\n| End of Day Share Price | 2025/08/05 00:00 |\n| Earnings | 2025/06/30 |\n| Annual Earnings | 2024/12/31 |\nData Sources\nThe data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.\n| Package | Data | Timeframe | Example US Source * |\n|---|---|---|---|\n| Company Financials | 10 years |\n| |\n| Analyst Consensus Estimates | +3 years |\n|\n|\n| Market Prices | 30 years |\n| |\n| Ownership | 10 years |\n| |\n| Management | 10 years |\n| |\n| Key Developments | 10 years |\n|\n* Example for US securities, for non-US equivalent regulatory forms and sources are used.\nUnless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.\nAnalysis Model and Snowflake\nDetails of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.\nLearn about the world class team who designed and built the Simply Wall St analysis model.\nIndustry and Sector Metrics\nOur industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.\nAnalyst Sources\nTactile Systems Technology, Inc. is covered by 13 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.\n| Analyst | Institution |\n|---|---|\n| null null | Argus Research Company |\n| Anderson Schock | B. Riley Securities, Inc. |\n| Kyle Bauser | B. Riley Securities, Inc. |"
    },
    {
      "url": "https://simplywall.st/company/id/B8520121-8444-4CBC-8177-2E715274AC69?blueprint=3969492&utm_medium=finance_user&utm_campaign=narratives-news-header&utm_source=yahoo&utm_content=narrative-header-company-report",
      "text": "Tactile Systems Technology (TCMD) Stock Overview\nA medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. More details\n| Snowflake Score | |\n|---|---|\n| Valuation | 5/6 |\n| Future Growth | 3/6 |\n| Past Performance | 2/6 |\n| Financial Health | 5/6 |\n| Dividends | 0/6 |\nTCMD Community Fair Values\nSee what 16 others think this stock is worth. Follow their fair value or set your own to get alerts.\nTactile Systems Technology, Inc. Competitors\nPrice History & Performance\n| Historical stock prices | |\n|---|---|\n| Current Share Price | US$12.54 |\n| 52 Week High | US$21.10 |\n| 52 Week Low | US$8.61 |\n| Beta | 0.96 |\n| 1 Month Change | 23.79% |\n| 3 Month Change | 30.08% |\n| 1 Year Change | -4.57% |\n| 3 Year Change | 33.40% |\n| 5 Year Change | -67.09% |\n| Change since IPO | 13.18% |\nRecent News & Updates\nTactile Systems Technology's (NASDAQ:TCMD) Soft Earnings Don't Show The Whole Picture\nMay 12Slammed 28% Tactile Systems Technology, Inc. (NASDAQ:TCMD) Screens Well Here But There Might Be A Catch\nMay 08Why Tactile Systems Technology, Inc. (NASDAQ:TCMD) Could Be Worth Watching\nMay 07Recent updates\nTactile Systems Technology's (NASDAQ:TCMD) Soft Earnings Don't Show The Whole Picture\nMay 12Slammed 28% Tactile Systems Technology, Inc. (NASDAQ:TCMD) Screens Well Here But There Might Be A Catch\nMay 08Why Tactile Systems Technology, Inc. (NASDAQ:TCMD) Could Be Worth Watching\nMay 07Tactile Systems Technology: Interesting Devices Company, Need More Clarity\nApr 07Tactile Systems Technology (NASDAQ:TCMD) Has A Rock Solid Balance Sheet\nFeb 23Investors Appear Satisfied With Tactile Systems Technology, Inc.'s (NASDAQ:TCMD) Prospects As Shares Rocket 26%\nNov 25Tactile Systems Technology, Inc. Just Recorded A 18% EPS Beat: Here's What Analysts Are Forecasting Next\nNov 07Nimbl Approval And Tech Investments Propel Growth Amid Shrinking Margins And Operational Risks\nInvestments in technology and workflow improvements, alongside FDA approval for Nimbl, indicate a strong focus on innovation and market expansion.Investors Holding Back On Tactile Systems Technology, Inc. (NASDAQ:TCMD)\nJul 17US$20.67: That's What Analysts Think Tactile Systems Technology, Inc. (NASDAQ:TCMD) Is Worth After Its Latest Results\nMay 09Tactile Systems Technology, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next\nFeb 23Does Tactile Systems Technology (NASDAQ:TCMD) Have A Healthy Balance Sheet?\nOct 10Capital Allocation Trends At Tactile Systems Technology (NASDAQ:TCMD) Aren't Ideal\nSep 16Is It Time To Consider Buying Tactile Systems Technology, Inc. (NASDAQ:TCMD)?\nJul 13Are Investors Undervaluing Tactile Systems Technology, Inc. (NASDAQ:TCMD) By 26%?\nMay 10Is Tactile Systems Technology (NASDAQ:TCMD) Using Too Much Debt?\nFeb 16Is Tactile Systems Technology (NASDAQ:TCMD) A Risky Investment?\nOct 12Tactile Systems Technology GAAP EPS of -$0.23 misses by $0.09, revenue of $59.6M beats by $2.72M\nAug 01Is Tactile Systems Technology (NASDAQ:TCMD) A Risky Investment?\nJun 14Investors Could Be Concerned With Tactile Systems Technology's (NASDAQ:TCMD) Returns On Capital\nJan 20Shareholder Returns\n| TCMD | US Medical Equipment | US Market | |\n|---|---|---|---|\n| 7D | 21.6% | -2.7% | -0.2% |\n| 1Y | -4.6% | 7.7% | 22.4% |\nReturn vs Industry: TCMD underperformed the US Medical Equipment industry which returned 10.6% over the past year.\nReturn vs Market: TCMD underperformed the US Market which returned 22.8% over the past year.\nPrice Volatility\n| TCMD volatility | |\n|---|---|\n| TCMD Average Weekly Movement | 12.4% |\n| Medical Equipment Industry Average Movement | 8.4% |\n| Market Average Movement | 6.5% |\n| 10% most volatile stocks in US Market | 17.6% |\n| 10% least volatile stocks in US Market | 3.1% |\nStable Share Price: TCMD's share price has been volatile over the past 3 months compared to the US market.\nVolatility Over Time: TCMD's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of US stocks.\nAbout the Company\n| Founded | Employees | CEO | Website |\n|---|---|---|---|\n| 1995 | 1,037 | Sheri Dodd | tactilemedical.com |\nTactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers. The company also provides Nimbl, a pneumatic compression platform for the treatment of upper extremity lymphedema; Kylee, a mobile application to help patients learn about lymphedema, track their symptoms, and treatment, as well as to share their progress with their doctor; and AffloVest, a portable high frequency chest wall oscillation vest to treat patients with retained pulmonary secretions resulting from bronchiectasis, cystic fibrosis, and various neuromuscular disorders.\nTactile Systems Technology, Inc. Fundamentals Summary\n| TCMD fundamental statistics | |\n|---|---|\n| Market cap | US$220.47m |\n| Earnings (TTM) | US$15.11m |\n| Revenue (TTM) | US$298.85m |\nIs TCMD overvalued?\nSee Fair Value and valuation analysisEarnings & Revenue\n| TCMD income statement (TTM) | |\n|---|---|\n| Revenue | US$298.85m |\n| Cost of Revenue | US$75.56m |\n| Gross Profit | US$223.30m |\n| Other Expenses | US$208.18m |\n| Earnings | US$15.11m |\nLast Reported Earnings\nJun 30, 2025\nNext Earnings Date\nn/a\n| Earnings per share (EPS) | 0.68 |\n| Gross Margin | 74.72% |\n| Net Profit Margin | 5.06% |\n| Debt/Equity Ratio | 12.7% |\nHow did TCMD perform over the long term?\nSee historical performance and comparisonCompany Analysis and Financial Data Status\n| Data | Last Updated (UTC time) |\n|---|---|\n| Company Analysis | 2025/08/05 06:44 |\n| End of Day Share Price | 2025/08/05 00:00 |\n| Earnings | 2025/06/30 |\n| Annual Earnings | 2024/12/31 |\nData Sources\nThe data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.\n| Package | Data | Timeframe | Example US Source * |\n|---|---|---|---|\n| Company Financials | 10 years |\n| |\n| Analyst Consensus Estimates | +3 years |\n|\n|\n| Market Prices | 30 years |\n| |\n| Ownership | 10 years |\n| |\n| Management | 10 years |\n| |\n| Key Developments | 10 years |\n|\n* Example for US securities, for non-US equivalent regulatory forms and sources are used.\nUnless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.\nAnalysis Model and Snowflake\nDetails of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.\nLearn about the world class team who designed and built the Simply Wall St analysis model.\nIndustry and Sector Metrics\nOur industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.\nAnalyst Sources\nTactile Systems Technology, Inc. is covered by 13 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.\n| Analyst | Institution |\n|---|---|\n| null null | Argus Research Company |\n| Anderson Schock | B. Riley Securities, Inc. |\n| Kyle Bauser | B. Riley Securities, Inc. |"
    },
    {
      "url": "https://simplywall.st/markets/us/healthcare/medical-equipment?blueprint=3969492&utm_medium=finance_user&utm_campaign=industry&utm_source=yahoo",
      "text": "Over the last 7 days, the Medical Equipment industry has dropped 2.7%, driven by pullbacks in Stryker and Intuitive Surgical of 6.4% and 5.3%, respectively. Over the past 12 months, the industry was up 7.7%. Earnings are forecast to grow by 12% annually.\nHas the U.S. Medical Equipment Industry valuation changed over the past few years?\n| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |\n|---|---|---|---|---|---|---|\n| Thu, 07 Aug 2025 | US$1.3t | US$290.7b | US$31.4b | 29.3x | 42x | 4.5x |\n| Sat, 05 Jul 2025 | US$1.4t | US$286.7b | US$29.6b | 30.8x | 46x | 4.7x |\n| Mon, 02 Jun 2025 | US$1.3t | US$286.7b | US$29.6b | 31.9x | 45.3x | 4.7x |\n| Wed, 30 Apr 2025 | US$1.3t | US$284.4b | US$28.3b | 31.6x | 46.1x | 4.6x |\n| Fri, 28 Mar 2025 | US$1.3t | US$283.3b | US$27.4b | 28.7x | 48.3x | 4.7x |\n| Sun, 23 Feb 2025 | US$1.4t | US$282.5b | US$30.1b | 31.7x | 46.7x | 5x |\n| Tue, 21 Jan 2025 | US$1.4t | US$284.0b | US$23.1b | 36.4x | 59.2x | 4.8x |\n| Thu, 19 Dec 2024 | US$1.3t | US$284.0b | US$23.6b | 34.4x | 55.9x | 4.6x |\n| Sat, 16 Nov 2024 | US$1.3t | US$283.1b | US$22.9b | 36.9x | 57.6x | 4.7x |\n| Mon, 14 Oct 2024 | US$1.3t | US$279.4b | US$22.1b | 37x | 59.2x | 4.7x |\n| Wed, 11 Sep 2024 | US$1.3t | US$279.6b | US$22.2b | 38x | 58.9x | 4.7x |\n| Fri, 09 Aug 2024 | US$1.2t | US$279.4b | US$21.9b | 35.9x | 55.4x | 4.3x |\n| Sun, 07 Jul 2024 | US$1.2t | US$276.4b | US$22.7b | 36.9x | 54.4x | 4.5x |\n| Tue, 04 Jun 2024 | US$1.2t | US$276.3b | US$22.7b | 37.4x | 54.5x | 4.5x |\n| Thu, 02 May 2024 | US$1.2t | US$276.1b | US$24.6b | 35.9x | 50.2x | 4.5x |\n| Sat, 30 Mar 2024 | US$1.3t | US$265.9b | US$22.6b | 40.9x | 58.1x | 4.9x |\n| Mon, 26 Feb 2024 | US$1.3t | US$265.9b | US$22.7b | 35.8x | 56.7x | 4.8x |\n| Wed, 24 Jan 2024 | US$1.2t | US$267.4b | US$20.2b | 38.5x | 61.9x | 4.7x |\n| Fri, 22 Dec 2023 | US$1.2t | US$267.4b | US$20.2b | 37.4x | 58.6x | 4.4x |\n| Sun, 19 Nov 2023 | US$1.1t | US$267.0b | US$19.7b | 35.2x | 56.2x | 4.1x |\n| Tue, 17 Oct 2023 | US$1.1t | US$263.9b | US$15.1b | 33.2x | 69.8x | 4x |\n| Thu, 14 Sep 2023 | US$1.2t | US$263.8b | US$15.0b | 34.1x | 77.9x | 4.4x |\n| Sat, 12 Aug 2023 | US$1.2t | US$263.4b | US$15.1b | 35.4x | 80.1x | 4.6x |\n| Mon, 10 Jul 2023 | US$1.3t | US$260.7b | US$16.2b | 36.8x | 77.7x | 4.8x |\n| Wed, 07 Jun 2023 | US$1.2t | US$261.2b | US$16.2b | 36.5x | 75.4x | 4.7x |\n| Fri, 05 May 2023 | US$1.3t | US$260.3b | US$16.7b | 37.7x | 75x | 4.8x |\n| Sun, 02 Apr 2023 | US$1.2t | US$260.2b | US$18.5b | 35.9x | 64.4x | 4.6x |\n| Tue, 28 Feb 2023 | US$1.1t | US$259.7b | US$18.7b | 38.5x | 61.5x | 4.4x |\n| Thu, 26 Jan 2023 | US$1.2t | US$262.5b | US$20.8b | 34.6x | 56.5x | 4.5x |\n| Sat, 24 Dec 2022 | US$1.1t | US$244.4b | US$19.0b | 31.9x | 58.5x | 4.5x |\n| Mon, 21 Nov 2022 | US$1.1t | US$244.5b | US$20.0b | 32.3x | 54.3x | 4.4x |\n| Wed, 19 Oct 2022 | US$1.0t | US$244.4b | US$26.5b | 32.2x | 39.5x | 4.3x |\n| Fri, 16 Sep 2022 | US$1.1t | US$244.6b | US$26.3b | 33.6x | 42.5x | 4.6x |\n| Sun, 14 Aug 2022 | US$1.2t | US$245.5b | US$26.7b | 34.4x | 44.1x | 4.8x |\n44.1x\nWhich industries have driven the changes within the U.S. Healthcare industry?\n| US Market | -0.16% | |\n| Healthcare | -2.74% | |\n| Medical Equipment | -2.72% | |\n| Medical Equipment | -2.69% | |\n| Medical Supplies | -3.25% |\nWhich companies have driven the market over the last 7 days?\n| Company | Last Price | 7D | 1Y | Valuation | |\n|---|---|---|---|---|---|\n| ABT Abbott Laboratories | US$130.93 | 1.9% +US$4.1b | 19.1% | PE16.4x | |\n| IDXX IDEXX Laboratories | US$624.19 | 9.1% +US$3.9b | 33.6% | PE50.7x | |\n| TMDX TransMedics Group | US$125.74 | 19.9% +US$739.7m | -19.4% | PE59.8x | |\n| ATEC Alphatec Holdings | US$15.20 | 41.7% +US$680.9m | 149.2% | PS3.3x | |\n| ALGN Align Technology | US$136.90 | 6.1% +US$571.9m | -36.1% | PE22.7x |"
    },
    {
      "url": "https://simplywall.st/discover/investing-ideas/282/quantum-computing-stocks/global?blueprint=3969492&utm_medium=finance_user&utm_campaign=investing-ideas&utm_source=yahoo&utm_content=quantum-computing",
      "text": "Results\n27\nExplore top quantum computing companies leading the revolution in next-gen technology, from pioneering hardware manufacturers to innovative software developers. These industry leaders are shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.\n27 companies\nQuantumCTek\nMarket Cap: CN\u00a528.1b\nManufactures and sells quantum information technology enabled information and communication technology security products and services in China.\n688027\nCN\u00a5271.10\n7D\n-1.1%\n1Y\n77.8%\nOptowide Technologies\nMarket Cap: CN\u00a56.1b\nEngages in the research, development, production, and sale of precision optics and fiber components in China and internationally.\n688195\nCN\u00a545.60\n7D\n-5.9%\n1Y\n106.6%\nIntellect Design Arena\nMarket Cap: \u20b9131.4b\nEngages in the development, marketing, and sale of integrated banking software systems in India and internationally.\nINTELLECT\n\u20b9947.00\n7D\n-7.4%\n1Y\n1.2%\nQuanta Computer\nMarket Cap: NT$1.1t\nManufactures, processes, and sells laptop computers and telecommunication products in the United States, Mainland China, the Netherlands, Japan, and internationally.\n2382\nNT$289.00\n7D\n2.7%\n1Y\n20.4%\nWonik IPS\nMarket Cap: \u20a91.5t\nResearches and develops, manufactures, and sells semiconductor, display, and solar cell systems in South Korea.\nA240810\n\u20a931,700.00\n7D\n-3.2%\n1Y\n-7.7%\nOxford Instruments\nMarket Cap: UK\u00a31.0b\nOxford Instruments plc provide scientific technology products and services for academic and commercial organizations in the United Kingdom and internationally.\nOXIG\nUK\u00a317.72\n7D\n-3.4%\n1Y\n-22.5%\nNagarro\nMarket Cap: \u20ac685.6m\nProvides digital product engineering and technology solutions in Germany, the United States of America, and internationally.\nNA9\n\u20ac54.25\n7D\n-4.0%\n1Y\n-29.8%\nClearwater Analytics Holdings\nMarket Cap: US$5.4b\nDevelops and provides a Software-as-a-Service (SaaS) solution for automated investment data aggregation, reconciliation, accounting, and reporting services to insurers, investment managers, corporations, institutional investors, and government entities in the United States and internationally.\nCWAN\nUS$20.42\n7D\n-2.1%\n1Y\n-9.2%\nViavi Solutions\nMarket Cap: US$2.2b\nProvides network test, monitoring, and assurance solutions for communications service providers, hyperscalers, network equipment manufacturers, original equipment manufacturers, government, and avionics customers in the Americas, the Asia-Pacific, Europe, the Middle East, and Africa.\nVIAV\nUS$10.04\n7D\n-1.3%\n1Y\n34.9%\nFormFactor\nMarket Cap: US$2.1b\nDesigns, manufactures, and sells probe cards, analytical probes, probe stations, thermal systems, cryogenic systems, and related services in the United States and internationally.\nFORM\nUS$27.62\n7D\n-2.8%\n1Y\n-38.0%\nOracle Corporation Japan\nMarket Cap: JP\u00a52.1t\nEngages in the development and sale of software and hardware products and solutions in Japan.\n4716\nJP\u00a516,810.00\n7D\n2.5%\n1Y\n37.2%\nNovanta\nMarket Cap: US$4.2b\nProvides precision medicine, precision manufacturing, medical solutions, robotics and automation solutions, and advanced surgery solutions in the United States and internationally.\nNOVT\nUS$113.74\n7D\n-7.7%\n1Y\n-32.4%\nMicrosoft\nMarket Cap: US$3.9t\nDevelops and supports software, services, devices, and solutions worldwide.\nMSFT\nUS$524.94\n7D\n2.3%\n1Y\n31.8%\nAlphabet\nMarket Cap: US$2.4t\nOffers various products and platforms in the United States, Europe, the Middle East, Africa, the Asia-Pacific, Canada, and Latin America.\nGOOGL\nUS$196.09\n7D\n2.2%\n1Y\n21.0%\nInternational Business Machines\nMarket Cap: US$233.5b\nProvides integrated solutions and services in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.\nIBM\nUS$252.28\n7D\n-3.1%\n1Y\n35.1%\nTencent Holdings\nMarket Cap: HK$5.2t\nAn investment holding company, provides value-added services, marketing services, fintech, and business services in Mainland China and internationally.\n700\nHK$567.00\n7D\n3.1%\n1Y\n54.0%\nOpen Text\nMarket Cap: US$7.4b\nEngages in the provision of information management products and services.\nOTEX\nUS$28.95\n7D\n-3.1%\n1Y\n-0.2%\nBTQ Technologies\nMarket Cap: CA$926.8m\nEngages in the development of computer-based technology related to post-quantum cryptography for applications in blockchain and related technologies.\nBTQ\nCA$6.30\n7D\n1.4%\n1Y\n1,557.9%\nD-Wave Quantum\nMarket Cap: US$5.8b\nDevelops and delivers quantum computing systems, software, and services worldwide.\nQBTS\nUS$17.58\n7D\n3.0%\n1Y\n2,070.4%\nIonQ\nMarket Cap: US$11.9b\nDevelops quantum computers and networks in the United States.\nIONQ\nUS$41.23\n7D\n3.4%\n1Y\n506.3%\nArqit Quantum\nMarket Cap: US$503.8m\nProvides cybersecurity services through satellite and terrestrial platforms in the United Kingdom.\nARQQ\nUS$34.74\n7D\n4.2%\n1Y\n350.9%\nSystena\nMarket Cap: JP\u00a5173.4b\nEngages in the solution and framework design, IT service, business solution, and cloud businesses in Japan.\n2317\nJP\u00a5499.00\n7D\n23.8%\n1Y\n46.3%\nQuantum Computing\nMarket Cap: US$2.5b\nAn integrated photonics company, provides quantum machines to commercial and government markets in the United States.\nQUBT\nUS$16.17\n7D\n9.0%\n1Y\n2,581.6%\nRigetti Computing\nMarket Cap: US$5.3b\nThrough its subsidiaries, builds quantum computers and the superconducting quantum processors the United States, the United Kingdom, rest of Europe, Asia, and internationally.\nRGTI\nUS$15.99\n7D\n12.8%\n1Y\n1,955.8%\nCheck Point Software Technologies\nMarket Cap: US$20.3b\nDevelops, markets, and supports a range of products and services for IT security worldwide.\nCHKP\nUS$188.21\n7D\n0.8%\n1Y\n5.7%\nHengtong Optic-Electric\nMarket Cap: CN\u00a539.6b\nOperates in the fiber optic communications industry in China, Europe, Latin America, Southeast Asia, the Middle East, and North Africa.\n600487\nCN\u00a516.06\n7D\n0.8%\n1Y\n12.8%\nQuanta Storage\nMarket Cap: NT$25.7b\nResearches, develops, produces, manufactures, and sells data storage and processing equipment, electronic components, optical instruments, and industrial robots in Mainland China, Thailand, the United States, Korea, Netherlands, Japan, and internationally.\n6188\nNT$92.20\n7D\n4.4%\n1Y\n-2.6%"
    }
  ],
  "argos_summary": "Tactile Systems Technology (TCMD) reported a profit margin decrease to 4.1% and earnings per share (EPS) of $0.14, both down from the previous quarter. Despite these declines, revenue exceeded analyst estimates by 6.7%, and EPS surpassed expectations by 30%. The company forecasts an average revenue growth of 8.6% per annum over the next three years, slightly above the industry average, while its shares have risen 22% recently, although there are two warning signs identified for potential investors.",
  "argos_id": "C1A6OJRI4"
}